Nebraska Raises Stakes in Battle With FDA, Won’t Surrender Supply of Controversial Drug

The state of Nebraska, engaged in an ongoing battle with the FDA over its supply of a controversial anesthetic drug used in executions, confirmed it will defy an FDA order to hand over remaining supplies of sodium thiopental.
Regulatory Focus